Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Care Innovation, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Care Innovation, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1635-1641.e1. doi: 10.1016/j.cgh.2020.06.047. Epub 2020 Jul 2.
BACKGROUND & AIMS: Financial incentives might increase participation in prevention such as screening colonoscopy. We studied whether incentives informed by behavioral economics increase participation in risk assessment for colorectal cancer (CRC) and completion of colonoscopy for eligible adults.
Employees of a large academic health system (50-64 y old; n = 1977) were randomly assigned to groups that underwent risk assessment for CRC screening and direct access colonoscopy scheduling (control), or risk assessment, direct access colonoscopy scheduling, a $10 loss-framed incentive to complete risk assessment, and a $25 unconditional incentive for colonoscopy completion (incentive). The primary outcome was the percentage of participants who completed screening colonoscopy within 3 months of initial outreach. Secondary outcomes included the percentage of participants who scheduled colonoscopy and the percentage who completed the risk assessment.
At 3 months, risk assessment was completed by 19.5% of participants in the control group (95% CI, 17.0-21.9%) and 31.9% of participants in the incentive group (95% CI, 29.0-34.8%) (P < .001). At 3 months, 0.7% of controls had completed a colonoscopy (95% CI, .2%-1.2%) compared with 1.2% of subjects in the incentive group (95% CI, .5%-1.9%) (P = .25).
In a randomized trial of participants who underwent risk assessment for CRC with vs without financial incentive, the financial incentive increased CRC risk assessment completion but did not result in a greater completion of screening colonoscopy. Clinicaltrials.gov no: NCT03068052.
经济激励措施可能会增加预防措施(如筛查结肠镜检查)的参与度。我们研究了基于行为经济学的激励措施是否会增加符合条件的成年人对结直肠癌(CRC)风险评估的参与度和完成结肠镜检查的比例。
大型学术医疗系统的员工(50-64 岁;n=1977)被随机分配到接受 CRC 筛查风险评估和直接预约结肠镜检查的组(对照组),或接受风险评估、直接预约结肠镜检查、完成风险评估的 10 美元损失框架激励、以及结肠镜检查完成的 25 美元无条件激励的组(激励组)。主要结果是在初始外展后 3 个月内完成筛查结肠镜检查的参与者比例。次要结果包括预约结肠镜检查的参与者比例和完成风险评估的参与者比例。
在 3 个月时,对照组有 19.5%的参与者完成了风险评估(95%CI,17.0-21.9%),激励组有 31.9%的参与者完成了风险评估(95%CI,29.0-34.8%)(P<0.001)。在 3 个月时,对照组中有 0.7%的参与者完成了结肠镜检查(95%CI,0.2%-1.2%),而激励组中有 1.2%的参与者完成了结肠镜检查(95%CI,0.5%-1.9%)(P=0.25)。
在一项对接受 CRC 风险评估的参与者进行的随机试验中,与没有经济激励的参与者相比,经济激励措施增加了 CRC 风险评估的完成率,但并没有导致更多的筛查结肠镜检查完成。Clinicaltrials.gov 编号:NCT03068052。